Movie

Ophelia

2019

Insufficient evidence

We did not find enough credible, independent evidence to publish a numeric cash-grab score. Unrated is more honest than a guess.

What counts as a cash grab?

Commercial extraction prioritized over meaningful consumer or creative value. Profit, popularity, adaptations, sequels, remakes, high budgets, and normal marketing do not count by themselves.

Why?

Ophelia (2019) was a festival-backed reimagining of Hamlet starring Daisy Ridley that received mixed to negative reviews and a limited theatrical run before quick digital availability. Distribution was handled by IFC Films with standard theatrical plus VOD windows, and reporting shows very modest box office returns. I found critical discussion of the film's execution and premise but no credible reporting of predatory monetization, deceptive release tactics, or packaged reuse intended to extract consumers beyond normal indie distribution practices.

No credible reporting found of predatory monetization or deceptive sales practices.
IFC Films acquired U.S. rights and used a standard limited theatrical plus VOD release strategy.
Film premiered on the festival circuit and is presented as a substantive reimagining of Hamlet.

View full breakdown

Score factors

Direction	Factor	Evidence	Impact
Against	Festival and creative positioning	Ophelia premiered on the festival circuit and was presented as a reimagining of Hamlet rather than a studio franchise installment.[1]	-14
Against	Cast and production credits	The film features established actors Daisy Ridley, Naomi Watts, and Clive Owen and lists multiple production companies and credited producers.[3]	-12
Against	Narrative originality	Ophelia is marketed and discussed as a perspective reimagining of Hamlet, based on a novel that centers Ophelia's viewpoint.[2]	-13
Against	Reviews focus on execution not exploitation	Major reviews (Guardian, Los Angeles Times, Slant) criticize the film's execution and ideas but do not allege predatory monetization or deliberate deceptive reuse.[1][5][7]	-11
Against	Very limited commercial returns	Box office reporting shows a very limited domestic take and small worldwide grosses, indicating the release did not generate major commercial extraction.[6][4]	-11
Against	IFC theatrical plus VOD release	IFC Films acquired U.S. rights and released the film in a limited theatrical window with rapid availability on digital/VOD, a standard IFC distribution model.[8]	-6

Confidence: Low · No source-backed commercial-extraction signal was found. · Researched 2026-09-27

Sources reviewed

View 11 more sources

Back to the woke verdict